Trial
NCT02084628
Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Bayer
Collaborators
—
Condition
Magnetic Resonance Imaging
Intervention
Gadoxetate disodium (Eovist/Primovist, BAY86-4873)
Why stopped
Enrollment discontinued due to rare medical condition in the age group 0 to 2 months
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-23